• Study of 18F-AlF-FAPI-74 PET/CT imaging compared to standard 18F-FDG PET/CT in patients with fever of unknown origin, IgG4-related disease, and axial spondyloarthritis

    Recruiting

    4 1 1
    Investigated Drugs:
    Belgium
  • Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium The Netherlands
  • Study of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Daratumumab for Reducing Symptoms in Patients with Moderate to Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    Norway
  • Study on Improving Sexual Health and Quality of Life in Cervical Cancer Patients Using Estriol, Estradiol Hemihydrate, and Promestriene

    Recruiting

    3 1 1 1
    Spain
  • Study Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Belgium Germany Ireland Italy Poland
  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    Denmark
  • Study on [18F]-AlF-FAPI-74 for Staging Advanced Stomach Cancer in Patients Using PET/CT and Laparoscopy

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by